BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14687610)

  • 1. Expression of lysosomal protective protein/cathepsin A in a stably transformed human neuroblastoma cell line during bi-directional differentiation into neuronal and Schwannian cells.
    Itoh K; Satoh Y; Kadota Y; Oheda Y; Kuwahara J; Shimmoto M; Sakuraba H
    Neurochem Int; 2004 May; 44(6):447-57. PubMed ID: 14687610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.
    Naganawa Y; Itoh K; Shimmoto M; Kamei S; Takiguchi K; Doi H; Sakuraba H
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):467-74. PubMed ID: 10333491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.
    van der Spoel A; Bonten E; d'Azzo A
    EMBO J; 1998 Mar; 17(6):1588-97. PubMed ID: 9501080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept.
    Cadaoas J; Hu H; Boyle G; Gomero E; Mosca R; Jayashankar K; Machado M; Cullen S; Guzman B; van de Vlekkert D; Annunziata I; Vellard M; Kakkis E; Koppaka V; d'Azzo A
    Mol Ther Methods Clin Dev; 2021 Mar; 20():191-203. PubMed ID: 33426146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis.
    Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A
    FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin A/protective protein: an unusual lysosomal multifunctional protein.
    Hiraiwa M
    Cell Mol Life Sci; 1999 Dec; 56(11-12):894-907. PubMed ID: 11212324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A.
    Bonten EJ; d'Azzo A
    J Biol Chem; 2000 Dec; 275(48):37657-63. PubMed ID: 10982818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.
    Zhang X; Hamada J; Nishimoto A; Takahashi Y; Murai T; Tada M; Moriuchi T
    J Cell Mol Med; 2007; 11(2):299-306. PubMed ID: 17488478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells.
    Itoh K; Takiyama N; Kase R; Kondoh K; Sano A; Oshima A; Sakuraba H; Suzuki Y
    J Biol Chem; 1993 Jan; 268(2):1180-6. PubMed ID: 8419322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
    Guo YK; Xie DH; Yang XM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective protein/cathepsin A loss in cultured cells derived from an early-infantile form of galactosialidosis patients homozygous for the A1184-G transition (Y395C mutation).
    Itoh K; Shimmoto M; Utsumi K; Mizoguchi N; Miharu N; Ohama K; Sakuraba H
    Biochem Biophys Res Commun; 1998 Jun; 247(1):12-7. PubMed ID: 9636645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calpain-calpastatin system is regulated differently during human neuroblastoma cell differentiation to Schwannian and neuronal cells.
    Saito Y; Saido TC; Sano K; Kawashima S
    FEBS Lett; 1994 Oct; 353(3):327-31. PubMed ID: 7957886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mutations in the PPBG gene lead to loss of PPCA protein which affects the level of the beta-galactosidase/neuraminidase complex and the EBP-receptor.
    Malvagia S; Morrone A; Caciotti A; Bardelli T; d'Azzo A; Ancora G; Zammarchi E; Donati MA
    Mol Genet Metab; 2004 May; 82(1):48-55. PubMed ID: 15110321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA.
    Rottier RJ; Hahn CN; Mann LW; del Pilar Martin M; Smeyne RJ; Suzuki K; d'Azzo A
    Hum Mol Genet; 1998 Oct; 7(11):1787-94. PubMed ID: 9736781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal high molecular weight multienzyme complex.
    Ostrowska H; Krukowska K; Kalinowska J; Orłowska M; Lengiewicz I
    Cell Mol Biol Lett; 2003; 8(1):19-24. PubMed ID: 12655352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neuroblastoma GOTO cells express CD44 and localize it into lipid rafts upon differentiation into Schwannian cells.
    Hasegawa G; Minami N; Kushida A; Inuyama H; Koga M; Wakabayashi K; Saito Y
    Cell Biol Int; 2005 Mar; 29(3):193-202. PubMed ID: 15878294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
    Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
    Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts.
    Hossain MA; Higaki K; Shinpo M; Nanba E; Suzuki Y; Ozono K; Sakai N
    Brain Dev; 2016 Feb; 38(2):175-80. PubMed ID: 26259553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.